Theranostics · 2020 · 51 citations · 63 references
MedicineEndocrinologyMolecular BiologyEpigeneticsGene ExpressionTranscriptional RegulationDiabetes MellitusInsulin ResistanceInsulin Signaling In MetabolismMetabolic SyndromeMicrorna BiologyMicrorna-mediated RegulationEndocrine-disrupting Chemical EffectsEnvironmental Endocrine DisruptionEpigenetic Gene RepressionInsulin Signaling Gene ExpressionInsulin Signaling PathwayMuscle Insulin SignalingSkeletal Muscle Insulin ResistanceSkeletal Muscle Physiology
The miR-17/Keap1-Nrf2/miR-200a axis contributed to DEHP-induced insulin resistance. miR-17 is a positive regulator, whereas miR-200a is a negative regulator of insulin signaling in skeletal muscle, and both miRNAs have the potential to become therapeutic targets for preventing and treating insulin resistance or type 2 diabetes.
63
Treatment of HCV Infection by Targeting MicroRNA
Harry L.A. Janssen, Hendrik W. Reesink, Eric Lawitz et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text
Alana G. Lerner, John-Paul Upton, Paurush Praveen et al. · Cell Metabolism · 2012 · 832 citations · Full text
Richard W. Stahlhut, Edwin van Wijngaarden, Timothy Dye et al. · Environmental Health Perspectives · 2007 · 642 citations · Full text